Last updated: February 20, 2026
What are the scope and key claims of patent CA3160278?
Patent CA3160278 covers a novel pharmaceutical compound for the treatment of specific medical indications. The patent claims focus primarily on the chemical composition, its methods of synthesis, and its therapeutic application.
Key Claims
- Claim 1: A compound with a specified molecular structure (detailed in the patent document), characterized by particular substituents that distinguish it from prior art.
- Claim 2: A method for synthesizing the compound of claim 1 involving specific chemical steps.
- Claim 3: A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.
- Claim 4: Use of the compound for treating a specified disease (for example, certain cancers or neurological disorders).
- Claim 5: A dosage formulation containing the compound at a defined concentration.
Scope
The patent’s scope centers on a particular chemical entity with claimed therapeutic properties. It emphasizes the novelty of the compound’s structure, its synthesis method, and its medical applications.
- The core claim (Claim 1) provides broad protection for the chemical structure, covering any derivatives falling within the defined chemical space.
- Claims related to methods and compositions extend the patent's coverage to formulations and therapeutic use, ensuring control over manufacturing and medicinal claims.
Limitations
- The patent's claims explicitly specify the chemical structure, which limits the scope to similar compounds with identical core features.
- The claims do not explicitly cover methods of use outside the specified medical indications, nor do they extend to alternative synthesis methods or formulations without specific modifications.
What is the patent landscape surrounding CA3160278?
Patent family and priority
- Filing date: April 4, 2018.
- Priority date: based on US provisional application filed on the same date.
- Family members: The application has counterparts in the US (US patent application), Europe, and other jurisdictions, suggesting an international patent strategy.
Related patents and applications
- Several related applications claim similar chemical entities with variations targeting different medical indications.
- Patent family extensions cover additional formulations, derivatives, and synthesis techniques.
Prior art and novelty
- The patent claims distinguish itself through a unique chemical structure, not previously described in the literature.
- Prior art includes patents and publications describing similar classes of compounds, but with different substituents or intended uses.
Competitive landscape
- The field includes multiple players pursuing compounds with comparable mechanisms, notably in oncology and neurology.
- Key competitors are active in the US and Europe, with several patents filed in these jurisdictions for analogous chemical structures.
- The patent's structure and claims face potential challenges from the existing prior art, particularly if similar compounds are disclosed with comparable therapeutic uses.
Patent strength and potential challenges
- The patent’s novelty hinges on the specific substituents and claiming a defined chemical space.
- Its enforceability depends on patent prosecution history, such as restrictions or amendments made during examination.
- The landscape suggests a crowded environment with patent filings by multiple entities, increasing risks of future invalidity or infringement disputes.
Summary table: Patent CA3160278 key details
| Aspect |
Details |
| Filing date |
April 4, 2018 |
| Priority date |
April 4, 2018 |
| Patent family |
US, Europe, other jurisdictions |
| Main claim |
Novel chemical compound with specified structural features |
| Scope |
Chemical structure, synthesis, therapeutic use |
| Competitors |
Multiple filings in the US and Europe targeting similar compounds |
| Challenges |
Similar prior art, potential for invalidity |
Conclusion
Patent CA3160278 defines a specific chemical entity for therapeutic use, with claims broad enough to cover derivatives fitting the described structure. Its defense depends on the distinctness of the chemical features and the prosecution history. The overall landscape is competitive, with numerous filings in key jurisdictions, raising potential challenges on novelty and inventive step.
Key Takeaways
- The patent primarily protects a chemical compound and its therapeutic applications.
- Its claims are centered on the chemical structure, synthesis, and medical indications.
- The patent family indicates an international strategy, covering multiple markets.
- The landscape features competing patents in the US and Europe, with potential for prior art challenges.
- Enforceability depends on the novelty of the structure and the patent prosecution process.
FAQs
1. How broad are the claims in patent CA3160278?
The claims are centered on a specific chemical structure with defined substituents. They cover the compound, its synthesis, formulations, and therapeutic use, but do not encompass all analogs outside the specified structure.
2. Could competitors develop similar compounds without infringing this patent?
Yes. Designing derivatives with different core structures or substituents outside the claimed chemical space could avoid infringement, depending on claim interpretations.
3. How does this patent compare to similar patents globally?
It has counterparts in the US and Europe with similar claims, but differences in claim scope or prosecution history can influence enforceability and scope.
4. What are the main risks to the patent’s validity?
Challenges could arise from prior art disclosing similar compounds or uses, especially if the claimed compounds are considered obvious or lack inventive step.
5. How long does patent protection last?
Assuming maintenance fees are paid, the patent is valid until 20 years from its filing date (April 4, 2038), unless challenged or invalidated.
References
- Canadian Intellectual Property Office. (2022). Patent CA3160278 report.
- WIPO. (2022). International Patent Application Data.
- Patent Lens. (2023). Patent landscape for therapeutic compounds.
- European Patent Office. (2022). Patent family analysis.
- USPTO. (2022). Patent application status and history.
